Skip to main content
The Journal of Physiology logoLink to The Journal of Physiology
. 2004 May 14;558(Pt 2):451–463. doi: 10.1113/jphysiol.2004.063792

Extrasynaptic NR2B and NR2D subunits of NMDA receptors shape ‘superslow’ afterburst EPSC in rat hippocampus

Natasha A Lozovaya 1, Sergei E Grebenyuk 1, Timur Sh Tsintsadze 1, Bihua Feng 2, Daniel T Monaghan 2, Oleg A Krishtal 1
PMCID: PMC1664978  PMID: 15146049

Abstract

In conditions of facilitated synaptic release, CA3/CA1 synapses generate anomalously slow NMDA receptor-mediated EPSCs (EPSCNMDA). Such a time course has been attributed to the cooperation of synapses through glutamate spillover. Imitating a natural pattern of activity, we have applied short bursts (2–7 stimuli) of high-frequency stimulation and observed a spike-to-spike slow-down of the EPSCNMDA kinetics, which accompanied synaptic facilitation. It was found that the early component of the EPSCNMDA and the burst-induced late component of the EPSCNMDA have distinct pharmacological properties. The competitive NMDA antagonist R-(—)-3-(2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid (D-CPP), which has higher affinity to NR2A than to NR2B subunits and lowest affinity at NR2D subunits, significantly slowed down the decay rate of the afterburst EPSC while leaving the kinetics of the control current unaffected. In contrast, ifenprodil, a highly selective NR2B antagonist, and [±]-cis-1-[phenanthren-2yl-carbonyl]piperazine-2,3-dicarboxylic acid (PPDA), a competitive antagonist that is moderately selective for NR2D subunits, more strongly inhibited the late component of the afterburst EPSCNMDA. The receptors formed by NR2B and (especially) NR2D subunits are known to have higher agonist sensitivity and much slower deactivation kinetics than NR2A-containing receptors. Furthermore, NR2B is preferentially and NR2D is exclusively located on extrasynaptic membranes. As the density of active synapses increases, the confluence of released glutamate makes EPSC decay much longer by activating more extrasynaptic NR2B- and NR2D-subunit-containing receptors. Long-term potentiation (LTP) induced by successive rounds of burst stimulation is accompanied by a long-term increase in the contribution of extrasynaptic receptors in the afterburst EPSCNMDA.


The spillover of synaptically released Glu described in numerous studies is important in the understanding of information processing in the hippocampus. The reason for this is straightforward. Since spillover implies intersynaptic cross-talk, the question is, whether such a highly cooperative synaptic system is capable of retaining address specificity in the processing of information. When studied in vitro, cooperative behaviour of CA3/CA1 synapses is displayed by the generation of the slow NMDA receptor-mediated EPSCs (EPSCNMDA) with kinetics dependent on the number of activated synapses. When this number is increased (or, alternatively, Glu uptake inhibited), EPSCNMDA becomes progressively slower, reaching durations in the range of seconds (Lozovaya et al. 1999; Arnth-Jensen et al. 2002). Interpreted in terms of spillover, such a duration implies the diffusion of released Glu well beyond immediately neighbouring synapses and its cooperative confluence on distant postsynaptic and extrasynaptic sites, which results in much delayed activation of receptors (Arnth-Jensen et al. 2002).

CA1 pyramidal cells express mRNA for three different NR2 NMDA receptor subunits: NR2A, NR2B and NR2D. This has been shown in adult humans (Scherzer et al. 1998) and in juvenile rats (Kirson et al. 1999; Hrabetova et al. 2000). Co-expression of NMDAR1 with one or more of the NR2 subunits generates receptors with distinct functional and pharmacological properties (Kutsuwada et al. 1992; Monyer et al. 1994; Vicini et al. 1998). Thus, deactivation times for diheteromeric NMDARs differ in a 50-fold range, following the sequence: NR2A < 2C = 2B ≪ 2D. The deactivation time constant for the macroscopic current mediated by NR1/NR2A assemblies comprises tens of milliseconds, compared to hundreds of milliseconds for NR1/NR2B and several seconds for NR1/NR2D receptors (Monyer et al. 1994; Vicini et al. 1998; Wyllie et al. 1998; Cull-Candy et al. 2001). The subunit composition of extrasynaptic and synaptic NMDA receptors in mature hippocampal neurones is asymmetrical: synaptic NMDA receptors contain NR2A (predominantly) and NR2B subunits, whereas extrasynaptic NMDA receptors contain mostly NR2B subunits (Tovar & Westbrook, 1999). Native NR2D subunit-incorporated receptors have been identified only extrasynaptically. There is no evidence so far for NR2D-containing receptors at any central synapse (Momiyama et al. 1996; Cull-Candy et al. 1998; Cull-Candy et al. 2001). It has been shown recently that NR2D-containing receptors are clearly present in the adult hippocampus (Thompson et al. 2002). Importantly, NR2D subunit-like immunoreactivity is evident in the dendrites of CA1 pyramidal cells. Pharmacological data indicate that several NMDA receptor blockers have differential selectivities among the various subunits of this receptor. Since the extrasynaptic receptors are expected to be much slower than the postsynaptic ones, their increased activity (as a consequence of spillover) should contribute to the ‘superslow’ kinetics of the EPSC. Using available pharmacological agents, we have tested this hypothesis.

Methods

Preparation of hippocampal slices

This study was carried out on Wistar rats (21 days old, WAG/GSto, Moscow, Russia). All experiments were performed in accordance with the guidelines of the Institutional Animal Care and Use Committee (protocol no. 2/0204). After decapitation, rat brains were immediately transferred to a chilled (4°C) solution of the following composition (mm): 120 NaCl, 5 KCl, 26 NaHCO3, 2 MgCl2, 0.5 CaCl2 and 20 glucose. The solution was constantly equilibrated with a gas mixture of 95% O2–5% CO2 to maintain a pH of 7.4. During the pre-incubation, the slices (300–400 μm thick) were kept fully submerged in the extracellular solution (mm): 135 NaCl, 5 KCl, 26 NaHCO3, 1.5 CaCl2, 1.5 MgCl2 and 20 glucose (pH 7.4, equilibrated with 95% O2–5% CO2). The experiments were conducted in a similar solution, but containing 2 mm CaCl2 and 1 mm MgCl2, at 32–34°C. Picrotoxin (50 μm) and (2S)-(+)-5,5-dimethyl-2-morpholineacetic acid (SCH 50911) (10 μm) were added to the extracellular solution to suppress inhibitory activity of interneurones.

Electrophysiological recordings in hippocampal slices

A standard whole-cell patch clamp technique was used to record EPSCs from CA1 pyramidal neurones in situ in response to stimulation of the Schaffer collateral–commissural pathway. To prevent the spread of electrical activity from area CA3, mini-slices were prepared by making a cut orthogonal to the stratum pyramidale and extending to the mossy fibres layer. Intracellular solution for patch pipettes contained (mm): 100 TrisPO4 or CsF, 40 NaH2PO4, 10 Hepes-CsOH and 10 Tris-Cl (pH 7.2). pH was adjusted with Tris OH or CsOH N-(2,6-dimethyl-phenylcarbamoylmethyl)-triethylammonium bromide (QX-314; 2–3 mm) was routinely added to the intracellular solution to block voltage-gated sodium conductance. Patch pipettes were pulled from soft borosilicate glass on a two-stage horizontal puller. When fire polished and filled with the intracellular solution, they had a resistance of 2–3 MΩ. Currents were digitally sampled at 400 μs intervals by a 12-digit ADC board and filtered at 3 kHz. Access resistance was monitored throughout the experiments and ranged typically from 6 to 9 MΩ. When the access resistance was changed by more than 25% during the experiment, the data were discarded. To stimulate the Schaffer collateral–commissural pathway, a bipolar Ni–Cr electrode was positioned on the surface of the slice. The current intensity of test stimuli (25–50 μA) was set to produce half-maximal EPSPs. Current pulses were delivered through the isolated stimulator HG 203 (Hi-Medical, London, UK) at 0.066–0.2 Hz. Student's unpaired t test was used for statistical analysis. Data are expressed as means ± s.e.m. Field potential recordings were conducted using tungsten electrode. Population spikes were measured in stratum pyramidale and field EPSPs were measured in stratum radiatum. Pharmacologically isolated EPSPNMDA was recorded in a modified extracellular solution containing 0.5 mm Mg2+ and 2.5 mm Ca2+ in the presence of 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f] quinoxaline-7-sulphonamide (NBQX).

NR subunit expression in Xenopus oocytes

cDNA encoding the NMDAR1a subunit was a generous gift of Dr Shigetada Nakanishi (Kyoto, Japan). cDNA encoding the NR2A, NR2C and NR2D were kindly provided by Dr Peter Seeburg (Heidelburg, Germany) and the NR2B [5′UTR] cDNA was the generous gift of Drs Dolan Pritchett and David Lynch (Philadelphia, PA, USA). Plasmids were linearized with Not I (NR1a), EcoR I (NR2A, NR2C and NR2D) or Sal I (NR2B) and transcribed in vitro with T3 (NR2A and NR2C), SP6 (NR2B) or T7 (NR1a and NR2D) RNA polymerase using the mMessage mMachine Transcription Kits (Ambion, Austin, TX, USA).

Oocytes were removed from mature female Xenopus laevis (Xenopus One, Ann Arbor, MI, USA) under anaesthesia as previously described (Buller et al. 1994). The frogs were humanely killed after the final collection. NMDA receptor subunit RNAs were dissolved in sterile distilled H2O. NR1a and NR2 RNAs were mixed in a molar ratio of 1:3. Fifty nanolitres of the final RNA mixture was microinjected (15–30 ng in total) into the oocyte cytoplasm. Oocytes were incubated in ND-96 oocyte culture medium (96 mm NaCl, 2 mm KCl, 1–8 mm CaCl2, 1 mm MgCl2, 5 mm Hepes) at 17°C prior to electrophysiological assay (1–5 days).

Electrophysiological recordings in Xenopus oocytes

Electrophysiological responses were measured using a standard two-microelectrode voltage clamp as previously described (Buller & Monaghan, 1997). The recording buffer contained (mm): 116 NaCl, 2 KCl, 2 BaCl2 and 5 Hepes, pH 7.4 (adjusted with NaOH). Response magnitude was determined by the steady plateau response elicited by bath application of 10 μm l-glutamate plus 10 μm glycine at a holding potential of −60 mV. Response amplitudes for the four heteromers were generally between 30 and 100 nA. Attempts were made to keep response magnitudes within this range to minimize activation of the endogenous Cl current. The presence of a plateau response was taken as an indication of the lack of significant activation of the endogenous Cl current by Ba2+ in these cells. Antagonist inhibition curves were fitted (GraphPad Prism, ISI Software, San Diego, CA, USA) according to the equation, I = ImaxImax/[1 + (IC50/A)n], where Imax is the current response in the absence of antagonist, A is the antagonist concentration and IC50 is the antagonist concentration producing half-maximal inhibition. Apparent Ki values were determined by correcting for agonist affinity according to the equation, IC50 = IC50(obs)/1 + ([agonist]/EC50), as described by Durand et al. (1992). ANOVA with a Newman–Keuls multiple comparison test was used for statistical analysis. Data are expressed as means ± s.e.m.

Drugs

Sodium bicarbonate and CsF were obtained from Merck (Darmstadt, FRG); lidocaine QX-314 and picrotoxin were purchased from RBI (Natick, MA, USA); and 6-nitro-7-sulphamoylbenzo[f]quinoxalin-2,3-dione (NBQX) was obtained from Tocris Cookson (Bristol, UK). All other chemicals were from Sigma (St Louis, MO, USA).

Results

The NMDA receptor-mediated component of the EPSC was measured in CA1 pyramidal cells in response to Schaffer collateral–commissural pathway stimulation in the presence of NBQX (10 μm). We applied short bursts (2–9 stimuli) of high-frequency stimulation that imitate natural stimulus patterns (Dobrunz & Stevens, 1999). Measurements were performed at a holding voltage of +50 mV (Fig. 1AD). In parallel, the experiments were performed at a holding voltage of −45 mV with similar results (Fig. 1E).

Figure 1. Superslow EPSCNMDA elicited by short trains of stimulation applied to the Schaffer collateral–commissural pathway.

Figure 1

The transferred charge depends on the number of stimuli within a short train. A, EPSCNMDA was induced by a single pulse (EPSCsingleNMDA, trace a) and by 7 pulses at 200 Hz (EPSCtrainNMDA, trace b). Trace c was obtained at a lower stimulus intensity (50% of control) than trace b. Holding voltage +50 mV. Here and hereafter, stimulation protocols are schematically represented over the traces; the peak amplitude of the EPSCNMDA has been measured as the mean over a 10 ms window around the peak. B, the averaged charge transferred by the EPSCsingleNMDA and EPSCtrainNMDA both normalized to the corresponding current peak amplitude. Here and hereafter, charge normalized to the peak amplitude is indicated as Q = charge/amplitude. The value obtained for the EPSCsingleNMDA is taken as 100%. C, the EPSCtrainNMDA elicited by a progressively increasing number of stimuli (from 1 to 9). Larger and slower traces correspond to a larger number of stimuli. D, charge transferred by the EPSCtrainNMDA as a function of stimuli number. E, representative traces of the EPSCNMDA induced by a single pulse (a) and by 7 pulses at 200 Hz (b) recorded at a holding potential of −45 mV. Traces on left are normalized.

The strength of the stimulus was adjusted to maintain the EPSC amplitudes in the range of 100–500 pA. In previous studies (Diamond, 2001; Arnth-Jensen et al. 2002) such amplitudes of current were shown not to be connected with major failures of voltage clamp that could at least qualitatively distort the changes in the EPSC time course.

When measured after a short train of stimuli (typically 7 stimuli applied at 200 Hz), the EPSCNMDA (EPSCtrainNMDA) was considerably facilitated, while its decay was dramatically slowed down. (Fig. 1A, traces a and b). This observation is in complete agreement with earlier data (Arnth-Jensen et al. 2002). The time course of alterations in the EPSCtrainNMDA were quantified by normalizing the charge transfer with the peak amplitude of the EPSCNMDA (measured as mean over 10 ms window around the peak). A larger charge transfer corresponds to slower decay kinetics and vice versa. Normalized charge transfer of the EPSCtrainNMDA was 240 ± 32% (P < 0.001, n = 32, Fig. 1B) of the same parameter for the EPSCNMDA induced by a single stimulus (EPSCsingleNMDA). Correspondingly, the half-decay time of EPSCsingleNMDA was 124 ± 20 ms, while the same value of the EPSCtrainNMDA was 428 ± 73 ms. The mean ratio of these parameters was 400 ± 96%, P < 0.002, n = 32.

For a given number of stimuli, the larger the stimulus applied, the greater this effect becomes (Fig. 1A traces b and c). Such behaviour is consistent with the spillout of l-glutamate from the synaptic cleft (Asztely et al. 1997; Diamond, 2001; Arnth-Jensen et al. 2002).

In many functional and behavioural states, natural spiking patterns in the brain are composed of relatively short periods of high-frequency activity. Specifically in hippocampus, pyramidal cells frequently have two to nine action potentials fired at frequencies up to 200 Hz (Kandel & Spencer, 1961; Rank, 1973; Suzuki & Smith, 1985). How significant is every spike within this small number? To address this question, we analysed the changes in the time course of EPSCs by varying the number of stimuli in the 200 Hz train. Figure 1C demonstrates that the gradual change in the EPSCNMDA kinetics becomes notable, starting even from the second stimulus. The dependence of the charge transferred by EPSCNMDA on the number of spikes in the short presynaptic burst is demonstrated in Fig. 1D. The saturation of the effect is observed after seven to nine stimuli. This indicates that a further increase in the number of stimuli would have negligible impact on NMDA receptor-mediated calcium signalling in a postsynaptic neurone.

Binary complexes of NMDA receptors composed of NR1 and NR2D subunits have been shown to display unique electrophysiological behaviour, including highest affinity for both glutamate and glycine (Ikeda et al. 1992), as well as extremely slow current deactivation (Monyer et al. 1994; Vicini et al. 1998), which fits well the time scale of decay of the afterburst EPSC. We therefore hypothesized that the extremely slow time course of the facilitated EPSC is due to the spillover of Glu and the subsequent activation of slowly deactivating extrasynaptic NR2B-containing receptors and NR2D-containing receptors. To check this hypothesis we used agents which preferentially block various NMDA receptor subunits. Thus, NR2D subunit-incorporating NMDA receptor can be distinguished by the competitive NMDA receptor antagonist D-CPP, which has a high preference for NR2A/B over NR2D subunits (Beaton et al. 1992; Buller et al. 1994). D-CPP Ki values were evaluated for recombinant NR2 subunits coexpressed with NR1a subunits in Xenopus oocytes. The corresponding Ki values were: NR2A, 41 ± 3 nm; NR2B, 270 ± 20 nm; NR2C, 630 ± 50 nm; and NR2D, 1990 ± 200 nm. NR2D affinity was statistically different from each of the other heterodimers by P < 0.001, n = 5.

Figure 2AC demonstrates that the delayed component of the EPSCtrainNMDA is more weakly inhibited by D-CPP than the current at the peak, while there is no change in the kinetics of EPSCsingleNMDA. In the presence of D-CPP (1 μm), normalized charge transfer for the EPSCtrainNMDA comprised 125 ± 7% of control values, versus 98 ± 7% for corresponding parameters for EPSCsingleNMDA (P < 0.02, n = 7, Fig. 2C). Correspondingly, D-CPP did not change t½ of EPSCsingleNMDA (110 ± 10% of control), while t½ of EPSCtrainNMDA was increased up to 166 ± 20% (n = 7; P < 0.02). These changes reflect much slower kinetics of the EPSCtrainNMDA decay under the action of D-CPP. Since the expression of NR2C-incorporating receptors has not been detected in the hippocampus of rats at this age (Kirson et al. 1999), this result could indicate the increased contribution of NR2D receptors in conditions of enhanced glutamate release. If this hypothesis is correct, then preferential inhibition of NR2D receptors over NR2A/B receptors would result in the opposite effect, that is acceleration of the EPSCtrainNMDA decay. Although antagonists highly selective for NR2D-containing receptors have not been described, PPDA demonstrates a small, but significant, preference for blocking NR2D-containing NMDA receptors compared to NR2A- and NR2B-containing receptors. PPDA Ki values for inhibiting the responses of recombinant NMDA receptors expressed in Xenopus oocytes are (nm): 680 ± 170 for NR1a/NR2A; 350 ± 2 for NR1a/NR2B; 70 ± 15 for NR1a/NR2C; and 108 ± 32 for NR1a/NR2D receptors (Hrabetova et al. 2000).

Figure 2. Delayed component of the afterburst EPSC displays lower sensitivity to D-CPP.

Figure 2

A, the late component of the EPSCtrainNMDA was inhibited by D-CPP much less than the current at the peak. The EPSCNMDA was evoked by a single pulse (trace a, control; b, with D-CPP), and by a 7 pulse train (trace c, control; d, with D-CPP; 200 Hz). Holding voltage was +50 mV. Lower line: corresponding traces normalized and superimposed; c and d, the subtraction of currents before and after application of D-CPP (normalized after subtraction). D-CPP does not alter the kinetics of the EPSCsingleNMDA, but slows down the kinetics of the EPSCtrainNMDA. B, the charge transferred by the EPSCsingleNMDA and the EPSCtrainNMDA normalized to the corresponding peak current amplitude recorded in control solution and in the presence of D-CPP. The value of Q obtained for the control EPSCsingleNMDA was taken as 100%. C, the ratio of normalized to the peak amplitude charges transferred by the EPSCNMDA recorded with and without D-CPP; calculated as Inline graphic.

We have found that PPDA (10 μm) strongly accelerates the decay rate of the EPSCtrainNMDA (Fig. 3). Correspondingly, the normalized charge transfer produced by the PPDA-sensitive component of the EPSCtrainNMDA was 51 ± 6% of control values, while the corresponding value for the EPSCsingleNMDA was only 7 ± 2%, P < 0.004, n = 7 (Fig. 3B and C). PPDA did not alter t½ of EPSCsingleNMDA (101 ± 22% of control), while t½ of EPSCtrainNMDA was decreased to 29 ± 9% (n = 5; P < 0.04). The concentration of PPDA used in this set of experiments was higher than those that follow from Ki values for inhibiting the responses of recombinant NMDA receptors expressed in Xenopus oocytes. The concentration of PPDA used in these experiments was in a good agreement with those that follow from Ki values for inhibiting the responses of recombinant NMDA receptors expressed in oocytes, despite the fact that the Ki values obtained from oocyte data cannot be entirely extrapolated to the slice experiments as the compound may possibly exhibit limited penetration into the brain tissue. In some experiments, the concentration of PPDA was empirically chosen to induce a significant (∼50%) block of the peak EPSC.

Figure 3. Delayed component of the EPSCtrainNMDA has higher sensitivity to PPDA than the EPSCsingleNMDA.

Figure 3

A, Upper traces: the EPSCNMDA evoked by a single pulse (traces a and b) and by a train 7 pulses long (traces c and d, 200 Hz) in control conditions (traces a and c) and with (±) cis-1-(phenanthren-2yl-carbonyl) piperazine-2,3-dicarboxylic acid (PPDA) (traces b and d). The late component of the EPSCtrainNMDA has a higher sensitivity to PPDA compared to the peak. Holding voltage was +50 mV. Lower traces: corresponding traces normalized and superimposed. B, the charge transfer of the EPSCsingleNMDA and the EPSCtrainNMDA normalized to the corresponding peak current amplitude; recordings in control solution and in the presence of PPDA. The Q value for the control EPSCsingleNMDA was taken as 100%. C, the contribution of the PPDA-sensitive component (QControlQPPDA) to the EPSCsingleNMDA and the EPSCtrainNMDA (calculated as Inline graphic).

The acceleration of EPSCtrainNMDA decay by PPDA may be mediated at least partly by the inhibition of NR2B subunit-containing receptors. However, elimination of the superslow (of the order of seconds) component of EPSCtrainNMDA (see Fig. 3A, traces c and d) further indicates the involvement of NR2D receptors.

Recently it has been demonstrated that in hippocampal pyramidal neurones NMDA receptors containing the NR2A subunit localize preferentially at synaptic sites, while the distribution of NR2B receptors is mostly extrasynaptic (Tovar & Westbrook, 1999). Both types of receptors are activated by stimulation of the Schaffer collateral–commissural pathway in hippocampal slices of adult mice (Kirson & Yaari, 1996). The noncompetitive antagonist ifenprodil effectively inhibits NR1/NR2B channels (IC50 = 0.34 μm), whereas the NR1/NR2A channels are inhibited with 400-fold lower affinity (IC50 = 146 μm) (Williams, 1993). Another NR2B-containing NMDA receptor, NR1/NR2A/NR2B, demonstrates intermediate affinity to ifenprodil (Kew et al. 1998).

According to the spillover hypothesis, the contribution of predominantly extrasynaptic NR2B subunit-containing receptors to the aftertrain EPSC should increase in the same manner as for NR2D subunit-containing receptors. Indeed, the delayed component of the EPSCtrainNMDA was inhibited by ifenprodil (30 μm) much stronger than the current in the peak (Fig. 4 traces c and d). The normalized charge transfer produced by the ifenprodil-sensitive component of the EPSCtrainNMDA was 39 ± 3% of control values, while the corresponding value for the EPSCsingleNMDA was 11 ± 2% (P < 0.001, n = 7, Fig. 4B and C). Correspondingly, ifenprodil only slightly altered t½ of EPSCsingleNMDA (91 ± 5% of control), while t½ of EPSCtrainNMDA was decreased to 45 ± 5% (n = 7; P < 0.02).

Figure 4. Increased contribution of the ifenprodil-sensitive component to the afterburst EPSCNMDA.

Figure 4

A, ifenprodil accelerates the decay of the EPSCtrainNMDA. Partial block by ifenprodil of the EPSCNMDA induced by a single pulse (traces a and b) and by 7 pulses at 200 Hz (traces c and d) with (traces b and d) and without (traces a and c) ifenprodil. Holding voltage was +50 mV (A). Lower traces: the traces normalized and superimposed. B, the charge transfer for the EPSCsingleNMDA and the EPSCtrainNMDA normalized to the corresponding current peak amplitude; recordings were made in control solution and in the presence of ifenprodil. The Q value obtained for the control EPSCsingleNMDA was taken as 100%. C, contribution of the ifenprodil-sensitive component (QControlQIfenprodil) to the EPSCsingleNMDA and the EPSCtrainNMDA (calculated as Inline graphic). D, enhancement of the block induced by ifenprodil at the peak of the EPSCtrainNMDA. Effect of ifenprodil on the peak value of EPSCNMDA evoked by single stimuli and trains.

It should be specifically noted that the non-competitive antagonist ifenprodil inhibits the peak of the EPSCtrainNMDA more strongly than EPSCsingleNMDA (40 ± 2% for EPSCtrainNMDA versus 77 ± 4% for EPSCsingleNMDA, P < 0,001, n = 7, Fig. 4D). This indicates the increased contribution of ifenprodil-sensitive receptors to the peak of the afterburst EPSC.

Thus, the increase in the transmitter release by a short train of 200 Hz stimulation (which imitates the natural burst pattern) results in the involvement of ‘slow’ NR2B and ‘superslow’ NR2 D extrasynaptic receptors in the EPSCNMDA. Figure 5A demonstrates the increase in the contribution of NR2B-containing receptors with the number of stimuli; saturation of the effect was observed after five to seven pulses (Fig. 5B and C).

Figure 5. The contribution of the ifenprodil-sensitive component to the EPSCtrainNMDA depends on the number of spikes in a burst.

Figure 5

A, the slow-down of the EPSCNMDA decay rate on a spike-to-spike basis. Upper traces: EPSCNMDA evoked by a single pulse (traces a and b), 2 pulses (traces c and d) and 7 pulses (traces e and f) of 200 Hz stimulation, recorded in control solution (traces a, c and e) and in the presence of ifenprodil (traces b, d and f). Holding voltage was +50 mV. Lower traces: corresponding traces normalized and superimposed. B, the charge transferred by control EPSCNMDA and the ifenprodil-sensitive component EPSCNMDA (QControlQIfenprodil) evoked by a progressively increasing number of pulses (from 1 to 7) in the train (200 Hz). The value obtained for EPSCsingleNMDA measured in control is taken as 100%. C, the contribution of the ifenprodil-sensitive component to the EPSCNMDA as a function of stimulation pulse number (from 1 to 7), 200Hz train (calculated as Inline graphic).

For a given number of stimuli in the train, the higher the frequency used, the greater are both the slow-down of the EPSCNMDA decay and the contribution of the ifenprodil-sensitive component. Short trains of 5 Hz stimulation induced much weaker, but detectable slow-down of EPSCNMDA decay (Fig. 6). However, in contrast to high-frequency stimulation, the major change was detectable after the second stimulus applied at a frequency of 5 Hz.

Figure 6. Increased contribution of the ifenprodil-sensitive component at theta- frequency stimulation.

Figure 6

A, the slow-down of EPSCNMDA on a spike-to-spike basis. Upper traces: EPSCNMDA evoked by a single pulse (traces a and b), 2 pulses (traces c and d) and 7 pulses (traces e and f); 5 Hz stimulation recorded in control solution (traces a, c and e) and in the presence of ifenprodil (traces b, d and f). Holding voltage +50 mV. Lower traces: corresponding traces normalized and superimposed. B, the charge transferred by the control EPSCNMDA and the ifenprodil-sensitive component EPSCNMDA (QControlQIfenprodil) evoked by a progressively increasing number of pulses (from 1 to 7) in the train (5 Hz). The control Q value for the EPSCsingleNMDA was taken as 100%. C, contribution of the ifenprodil-sensitive component to the EPSCNMDA evoked by progressively increasing the number of pulses (from 1 to 7) in a 5 Hz train (calculated as Inline graphic).

In a separate set of experiments, pharmacologically isolated NMDA receptor-mediated field EPSPs (EPSPNMDA) were induced by short trains of 5 Hz stimulation. We have found that the contribution of the ifenprodil-sensitive component increases with stimulus number in the train (Fig. 7). The extent of inhibition of EPSP produced by ifenprodil for the first stimulus was 52 ± 9% as compared to 71 ± 10% for the seveth stimulus (n = 4, P < 0.05). Ifenprodil only slightly altered t½ of EPSCsingleNMDA (102 ± 13% of control), while t½ of EPSCtrainNMDA was decreased to 75 ± 14% of control values (n = 4; P < 0.04).

Figure 7. Pharmacologically isolated field EPSPNMDA measured during the course of 5 Hz stimulation.

Figure 7

A, the traces of the EPSPNMDA induced by a train 7 pulses long (5 Hz) in control conditions and in the presence of 50 μm ifenprodil (superimposed). B, corresponding traces were normalized. The peak values of individual EPSPs are marked with dashes to demonstrate a gradual pulse-to-pulse increase in the contribution of ifenprodil-sensitive component of the signal.

For hippocampus and cortex, high-frequency bursts are believed to be associated with information processing and memory consolidation. Imitation of these natural stimulus patterns is known to result in robust long-term potentiation (LTP; Dobrunz & Stevens, 1999). Some data indicate that the LTP phenomenon is accompanied by presynaptic changes, which include an increase in release probability and in the number of effective release sites (Malinow & Tsien, 1990; Bolshakov & Siegelbaum, 1995; Sokolov et al. 2002), but for comparison see Nicoll & Malenka (1995) and Diamond et al. (1998). We produced LTP in the CA1 hippocampal region by using a high-frequency stimulation (HFS) protocol (6 trains of 7 pulses each, 200 Hz). Mean post-tetanic changes comprised 210 ± 42% (P < 0.01, n = 4) for the amplitudes of field potential (data not shown) and 161 ± 21% (P < 0.02, n = 5) for the amplitude of EPSCsingleNMDA (Fig. 8A and D). In this set of experiments, EPSCNMDA were measured in the presence of NBQX, while field potential recordings were conducted without NBQX. Pharmacologically isolated NMDA receptor-mediated synaptic responses demonstrate robust LTP (Bashir et al. 1991; Asztely et al. 1992). When measured after HFS, EPSCNMDA induced by a 5 Hz train displayed significant long-term slow-down of the decay, while the kinetics of the EPSCsingleNMDA were only slightly altered or remained unchanged (Fig. 8A). The effect persisted at least for 1.5 h. In the control experiments (without HFS) no changes of the EPSCtrainNMDA were observed for at least 90 min (Fig. 8B). Correspondingly, 60 min after HFS the relation between normalized charge transfer for the EPSCtrainNMDA and EPSCsingleNMDA comprised 136 ± 13% of the control values (P < 0.07, n = 5, Fig. 8C). The ratio of t½ of EPSCtrainNMDA and t½ of EPSCsingleNMDA was 154 ± 25% (P < 0.05, n = 5).

Figure 8. Long-term enhancement of the delayed component of the afterburst EPSCNMDA after HFS.

Figure 8

A, left-hand traces: EPSCNMDA induced by single stimuli (traces a and b) and by a 5 Hz train 7 pulses long (traces c and d) before (traces a and c) and 60 min after HFS (traces b and d). HFS stimulation protocol was as follows: train 7 pulses long (200 Hz) was applied 6 times with 20 s intervals. Holding voltage was −45 mV. Right-hand traces: corresponding EPSCNMDA scaled to the same amplitude and superimposed as indicated. B, control experiment demonstrating the lack of slow-down of the EPSCtrainNMDA in the course of long-term measurements (90 min) in the absence of HFS. The EPSCNMDA induced by a train (5 Hz) 7 pulses long before (trace e) and after 90 min of the whole-cell recording (trace f). Both traces exactly coincide, as seen in the normalized superposition at a higher sweep speed (right-hand traces). C, train-to-single ratio of the normalized charge to the peak charge transfer measured in control conditions, immediately after HFS and successively at 30, 60 and 90 min after HFS (calculated as Inline graphic). D, averaged amplitude of the EPSCNMDA induced by single stimulus measured in control conditions, immediately after, and at 30, 60 and 90 min after HFS.

Discussion

We have found that pharmacological agents that preferentially inhibit slowly deactivating NMDA receptor subtypes speed up the kinetics of ultraslow afterburst EPSCs, while D-CPP, which is most effective against more rapid NR2A/B subunits, makes the afterburst EPSC kinetics substantially slower. In all of these cases, the kinetics of EPSCNMDA elicited by a single pulse remained unaffected. Among other consequences, these data indicate that the slow-down of the afterburst EPSC is not connected to the increase in the current amplitude and consequent voltage clamp and filtration problems; while the afterburst EPSCNMDA amplitude was inhibited in all cases, the direction of the kinetics changes depended on the pharmacological profile of the drug applied. This observation seems to be especially important because our data indicate that the use of slowly dissociating NMDA receptor blockers for evaluating the fidelity of the voltage clamp in the in situ pyramidal neurones is limited by their NMDA receptor subtype specificity.

According to a recently suggested interpretation, hippocampal ultraslow EPSCs reflect spatial/temporal limitations of uptake mechanisms in conditions of synchronized neuronal activity (Arnth-Jensen et al. 2002). Cooperativity of densely packed CA3/CA1 synapses has been suggested as the primary consequence of these uptake limitations. Our data do not exclude a role of synaptic cross-talk in the spillover phenomenology but indicate that a substantial role in shaping the ultraslow afterburst EPSCNMDA belongs to the pharmacologically distinct slowly deactivating NMDA receptor subunits. Evidently, some of them become recruited very rapidly after the massive synchronized release of Glu; the contribution of the ifenprodil-sensitive component is already increased at the peak of afterburst EPSC (Fig. 4).

The following question arises: does the train stimulation activate a pool of extrasynaptic receptors or lead to the recruitment of synaptic receptors with different properties? Experiments with low-affinity competitive NMDA receptor antagonist d-aminoadipic acid (d-AA), whose efficacy depends on the concentration of glutamate (Clements et al. 1992), allow distinguishing receptors activated within active synapses from those activated by spillover (Diamond, 1999). It has been found that while leaving the kinetics of EPSCsingleNMDA practically unaltered, d-AA markedly reduces the late component of EPSCtrainNMDA (Grebenyuk et al. 2004). The present data demonstrate that the same component is inhibited by ifenprodil and PPDA.

Although numerous studies suggest synaptic localization for NMDA receptors, they are definitely also present at extrasynaptic sites (Rosenmund et al. 1995; Rao & Craig, 1997; Clark et al. 1997; Rao et al. 1998). Importantly, ifenprodil blocks the EPSC less effectively than the whole-cell current, which includes both synaptic and extrasynaptic receptors (Tovar & Westbrook, 1999). Non-synaptic NMDA receptor clusters have been reported to be prominent in developing cortical tissue, some of them remaining intracellular and some being associated with the plasma membrane (Aoki et al. 1994; Johnson et al. 2003). NMDA receptor clusters non-colocalized with presynaptic markers were detected in numerous studies using cultured hippocampal neurones and immunocytochemical methods (Aoki et al. 1994; Liao et al. 1999; Pickard et al. 2000). Recent evidence suggests that NMDA receptors are highly dynamic and can move laterally between synaptic and extrasynaptic pools (Tovar & Westbrook, 2002). Distinct regulation of synaptic versus extrasynaptic NMDA receptors has been reported (Li et al. 2002); Ca2+ and tyrosine phosphorylation differentially regulate run-down of synaptic versus extrasynaptic NMDA receptor-mediated current in rat hippocampal pyramidal neurones, providing mechanisms for receptor adaptation to a variety of stimuli. Furthermore, varying cellular consequences of NMDA receptor activation ((cAMP response element binding protein) CREB function, gene regulation and neurone survival)) were specified for the synaptic versus extrasynaptic location of the receptors activated in cultured hippocampal neurones (Hardingham et al. 2002).

At present it is not known which di- and/or triheteromeric NR2D-containing NMDA receptor assemblies are expressed in hippocampus in vivo and how the inclusion of NR2D in such assemblies affects distinct single-channel properties. Immunohistochemical data suggest that all NR2D-containing receptors in the adult midbrain may be triheteromeric (Dunah et al. 1998). The expression of NR1/NR2D and NR1/NR2B/NR2D assemblies has been demonstrated recently in cerebellar Golgi cells (Brickley et al. 2003). The triheteromeric NR1/NR2B/NR2D assembly generates channels with properties distinct from NR2B and NR2D, in particular, with intermediate sensitivity to ifenprodil. Therefore, at present it is difficult to specify whether the ifenprodil-sensitive component of EPSCNMDA recorded in our experiments corresponds to pure NR2B or NR2B-containing receptor assemblies.

We demonstrate here that robust LTP, produced by repetitive high-frequency stimulation, is accompanied by a long-term increase in the contribution of extrasynaptic NMDA receptors to the aftertrain EPSC. The increased contribution of extrasynaptic receptors after HFS could be a result of the long-term increase in glutamate release that has been shown to occur in CA3/CA1 synapses after induction of LTP (Malinow & Tsien, 1990; Bolshakov & Siegelbaum, 1995; Sokolov et al. 2002), though modification in glutamate uptake machinery cannot be excluded. Plasticity involving extrasynaptic NMDA receptors could be important for memory consolidation processes, that, according to the ‘synaptic re-entry reinforcement hypothesis’, require multiple rounds of NMDA receptor-dependent modification to reinforce the synaptic changes initiated during memory acquisition (Shimizu et al. 2000; Wittenberg & Tsien, 2002). Experiments with Ca2+ imaging reveal that NMDA receptors play a leading role in creating the postsynaptic Ca2+ signal (Kovalchuk et al. 2000). NR2B receptors have a higher Ca2+ permeability than NR2A (Dingledine et al. 1999). The enhancement of their activity on a spike-to-spike basis may well account for the ability of bursts to make synaptic transmission reliable and to cause plasticity (Lisman, 1997). In particular, the NR2B subunit has been suggested to have a critical role in spatial learning and LTP, as evidenced by NR2B knockout and overexpressing mice (Sprengel et al. 1998; Tang et al. 1999; Tovar et al. 2000). Tang et al. (1999) showed that mice in which the NR2B subunit of the NMDA receptor is overexpressed display a striking increase in synaptic plasticity and learning ability. A role for NR2D in hippocampal long-term depression (LTD) has been recently proposed (Hrabetova et al. 2000).

In summary, our data indicate that the phenomenon of ‘ultraslow’ EPSCNMDA comprises the recruitment of ultraslow NMDA receptor subtypes. Their extrasynaptic location indicates that spillover results in the activation of non-synaptic routes of calcium entry into the dendrite. Correspondingly, the stimulus dependence of the EPSCNMDA kinetics can reflect a confluence of transmitter over extrasynaptic spaces. Taking into account independent compartmentalization of spines and extrasynaptic intracellular calcium pools (Yuste & Tank, 1996; Sabatini et al. 2001), the kill as large as the loss of synaptic specificity may become unnecessary. To answer the question of how much genuine intersynaptic cross-talk is involved, one needs more specific pharmacological tools and/or other approaches. Evidently, as for the consequences of spillover for synaptic plasticity, a more ‘complicated scenario’ (Diamond, 2002) is needed for their interpretation; the role(s) of intradendritic calcium should be considered.

Acknowledgments

This work was supported by the Wellcome Trust, Howard Hughes Medical Institute and RO1 MH60252 grants.

References

  1. Aoki C, Venkatesan C, Go CG, Mong JA, Dawson TM. Cellular and subcellular localization of NMDA-R1 subunit immunoreactivity in the visual cortex of adult and neonatal rats. J Neurosci. 1994;14:5202–5222. doi: 10.1523/JNEUROSCI.14-09-05202.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arnth-Jensen N, Jabaudon D, Scanziani M. Cooperation between independent hippocampal synapses is controlled by glutamate uptake. Nat Neurosci. 2002;5:325–331. doi: 10.1038/nn825. [DOI] [PubMed] [Google Scholar]
  3. Asztely F, Erdemli G, Kullmann DM. Extrasynaptic glutamate spillover in the hippocampus: dependence on temperature and the role of active glutamate uptake. Neuron. 1997;18:281–293. doi: 10.1016/s0896-6273(00)80268-8. [DOI] [PubMed] [Google Scholar]
  4. Asztely F, Wigstrom H, Gustafsson B. The relative contribution of NMDA receptor channels in the expression of long-term potentiation in the hippocampal CA1 region. Eur J Neurosci. 1992;4:681–690. doi: 10.1111/j.1460-9568.1992.tb00177.x. [DOI] [PubMed] [Google Scholar]
  5. Bashir ZI, Alford S, Davies SN, Randall AD, Collingridge GL. Long-term potentiation of NMDA receptor-mediated synaptic transmission in the hippocampus. Nature. 1991;349:156–158. doi: 10.1038/349156a0. [DOI] [PubMed] [Google Scholar]
  6. Beaton JA, Stemsrud K, Monaghan DT. Identification of a novel N-methyl-d-aspartate receptor population in the rat medial thalamus. J Neurochem. 1992;59:754–757. doi: 10.1111/j.1471-4159.1992.tb09433.x. [DOI] [PubMed] [Google Scholar]
  7. Bolshakov VY, Siegelbaum SA. Regulation of hippocampal transmitter release during development and long-term potentiation. Science. 1995;269:1730–1734. doi: 10.1126/science.7569903. [DOI] [PubMed] [Google Scholar]
  8. Brickley SG, Misra C, Mok MH, Mishina M, Cull-Candy SG. NR2B and NR2D subunits coassemble in cerebellar Golgi cells to form a distinct NMDA receptor subtype restricted to extrasynaptic sites. J Neurosci. 2003;23:4958–4966. doi: 10.1523/JNEUROSCI.23-12-04958.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Buller AL, Larson HC, Schneider BE, Beaton JA, Morrisett RA, Monaghan DT. The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition. J Neurosci. 1994;14:5471–5484. doi: 10.1523/JNEUROSCI.14-09-05471.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Buller AL, Monaghan DT. Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes. Eur J Pharmacol. 1997;320:87–94. doi: 10.1016/s0014-2999(96)00880-1. [DOI] [PubMed] [Google Scholar]
  11. Clark BA, Farrant M, Cull-Candy SG. A direct comparison of the single-channel properties of synaptic and extrasynaptic NMDA receptors. J Neurosci. 1997;17:107–116. doi: 10.1523/JNEUROSCI.17-01-00107.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Clements JD, Lester RA, Tong G, Jahr CE, Westbrook GL. The time course of glutamate in the synaptic cleft. Science. 1992;258:1498–1501. doi: 10.1126/science.1359647. [DOI] [PubMed] [Google Scholar]
  13. Cull-Candy S, Brickley S, Farrant M. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol. 2001;11:327–335. doi: 10.1016/s0959-4388(00)00215-4. [DOI] [PubMed] [Google Scholar]
  14. Cull-Candy SG, Brickley SG, Misra C, Feldmeyer D, Momiyama A, Farrant M. NMDA receptor diversity in the cerebellum: identification of subunits contributing to functional receptors. Neuropharmacology. 1998;37:1369–1380. doi: 10.1016/s0028-3908(98)00119-1. [DOI] [PubMed] [Google Scholar]
  15. Diamond JS. Neuronal glutamate transporters limit activation of NMDA receptors by neurotransmitter spillover on CA1 pyramidal cells. J Neurosci. 2001;21:8328–8338. doi: 10.1523/JNEUROSCI.21-21-08328.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Diamond JS. Neuronal glutamate transporters limit activation of NMDA receptors by neurotransmitter spillover on CA1 pyramidal cells. J Neurosci. 2001;21:8328–8338. doi: 10.1523/JNEUROSCI.21-21-08328.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Diamond JS. A broad view of glutamate spillover. Nat Neurosci. 2002;5:291–292. doi: 10.1038/nn0402-291. [DOI] [PubMed] [Google Scholar]
  18. Diamond JS, Bergles DE, Jahr CE. Glutamate release monitored with astrocyte transporter currents during LTP. Neuron. 1998;21:425–433. doi: 10.1016/s0896-6273(00)80551-6. [DOI] [PubMed] [Google Scholar]
  19. Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol Rev. 1999;51:7–61. [PubMed] [Google Scholar]
  20. Dobrunz LE, Stevens CF. Response of hippocampal synapses to natural stimulation patterns. Neuron. 1999;22:157–166. doi: 10.1016/s0896-6273(00)80687-x. [DOI] [PubMed] [Google Scholar]
  21. Dunah AW, Luo J, Wang YH, Yasuda RP, Wolfe BB. Subunit composition of N-methyl-d-aspartate receptors in the central nervous system that contain the NR2D subunit. Mol Pharmacol. 1998;53:429–437. doi: 10.1124/mol.53.3.429. [DOI] [PubMed] [Google Scholar]
  22. Durand GM, Gregor P, Zheng X, Bennett MV, Uhl GR, Zukin RS. Cloning of an apparent splice variant of the rat N-methyl-d-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C. Proc Natl Acad Sci U S A. 1992;89:9359–9363. doi: 10.1073/pnas.89.19.9359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Grebenyuk S, Lozovaya N, Tsintsadze T, Krishtal O. Post-synaptic NMDA signalling in hippocampal neurons of rat: spillover increases the impact of each spike in a short burst discharge. Neuroscience Letters. 2004;367:60–66. doi: 10.1016/j.neulet.2004.02.040. [DOI] [PubMed] [Google Scholar]
  24. Hardingham GE, Fukunaga Y, Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci. 2002;5:405–414. doi: 10.1038/nn835. [DOI] [PubMed] [Google Scholar]
  25. Hrabetova S, Serrano P, Blace N, Tse HW, Skifter DA, Jane DE, et al. Distinct NMDA receptor subpopulations contribute to long-term potentiation and long-term depression induction. J Neurosci. 2000;20:1–6. doi: 10.1523/JNEUROSCI.20-12-j0002.2000. RC81: [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ikeda K, Nagasawa M, Mori H, Araki K, Sakimura K, Watanabe M, et al. Cloning and expression of the epsilon 4 subunit of the NMDA receptor channel. FEBS Lett. 1992;313:34–38. doi: 10.1016/0014-5793(92)81178-o. [DOI] [PubMed] [Google Scholar]
  27. Johnson RR, Jiang X, Burkhalter A. Regional and laminar differences in synaptic localization of NMDA receptor subunit NR1 splice variants in rat visual cortex and hippocampus. J Comp Neurol. 2003;368:335–355. doi: 10.1002/(SICI)1096-9861(19960506)368:3<335::AID-CNE2>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
  28. Kandel ER, Spencer WA. Electrophysiology of hippocampal neurons. II. After-potentials and repetitive firing. J Neurophysiol. 1961;24:243–259. doi: 10.1152/jn.1961.24.3.243. [DOI] [PubMed] [Google Scholar]
  29. Kew JN, Richards JG, Mutel V, Kemp JA. Developmental changes in NMDA receptor glycine affinity and ifenprodil sensitivity reveal three distinct populations of NMDA receptors in individual rat cortical neurons. J Neurosci. 1998;18:1935–1943. doi: 10.1523/JNEUROSCI.18-06-01935.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kirson ED, Schirra C, Konnerth A, Yaari Y. Early postnatal switch in magnesium sensitivity of NMDA receptors in rat CA1 pyramidal cells. J Physiol. 1999;521:99–111. doi: 10.1111/j.1469-7793.1999.00099.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kirson ED, Yaari Y. Synaptic NMDA receptors in developing mouse hippocampal neurones: functional properties and sensitivity to ifenprodil. J Physiol. 1996;497:437–455. doi: 10.1113/jphysiol.1996.sp021779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kovalchuk Y, Eilers J, Lisman J, Konnerth A. NMDA receptor-mediated subthreshold Ca2+ signals in spines of hippocampal neurons. J Neurosci. 2000;20:1791–1799. doi: 10.1523/JNEUROSCI.20-05-01791.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K, et al. Molecular diversity of the NMDA receptor channel. Nature. 1992;358:36–41. doi: 10.1038/358036a0. [DOI] [PubMed] [Google Scholar]
  34. Li B, Chen N, Luo T, Otsu Y, Murphy TH, Raymond LA. Differential regulation of synaptic and extra-synaptic NMDA receptors. Nat Neurosci. 2002;5:833–834. doi: 10.1038/nn912. [DOI] [PubMed] [Google Scholar]
  35. Liao D, Zhang X, O'Brien R, Ehlers MD, Huganir RL. Regulation of morphological postsynaptic silent synapses in developing hippocampal neurons. Nat Neurosci. 1999;2:37–43. doi: 10.1038/4540. [DOI] [PubMed] [Google Scholar]
  36. Lisman JE. Bursts as a unit of neural information: making unreliable synapses reliable. Trends Neurosci. 1997;20:38–43. doi: 10.1016/S0166-2236(96)10070-9. [DOI] [PubMed] [Google Scholar]
  37. Lozovaya NA, Kopanitsa MV, Boychuk YA, Krishtal OA. Enhancement of glutamate release uncovers spillover-mediated transmission by N-methyl-d-aspartate receptors in the rat hippocampus. Neuroscience. 1999;91:1321–1330. doi: 10.1016/s0306-4522(98)00638-1. [DOI] [PubMed] [Google Scholar]
  38. Malinow R, Tsien RW. Presynaptic enhancement shown by whole-cell recordings of long-term potentiation in hippocampal slices. Nature. 1990;346:177–180. doi: 10.1038/346177a0. [DOI] [PubMed] [Google Scholar]
  39. Momiyama A, Feldmeyer D, Cull-Candy SG. Identification of a native low-conductance NMDA channel with reduced sensitivity to Mg2+ in rat central neurones. J Physiol. 1996;494:479–492. doi: 10.1113/jphysiol.1996.sp021507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 1994;12:529–540. doi: 10.1016/0896-6273(94)90210-0. [DOI] [PubMed] [Google Scholar]
  41. Nicoll RA, Malenka RC. Contrasting properties of two forms of long-term potentiation in the hippocampus. Nature. 1995;377:115–118. doi: 10.1038/377115a0. [DOI] [PubMed] [Google Scholar]
  42. Pickard L, Noel J, Henley JM, Collingridge GL, Molnar E. Developmental changes in synaptic AMPA and NMDA receptor distribution and AMPA receptor subunit composition in living hippocampal neurons. J Neurosci. 2000;20:7922–7931. doi: 10.1523/JNEUROSCI.20-21-07922.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Rank JB. Studies on single neurons in dorsal hippocampal formation and septum in unrestrained rats. 1. Behavioral correlates and firing repertoires. Exp Neurol. 1973;41:462–531. doi: 10.1016/0014-4886(73)90290-2. [DOI] [PubMed] [Google Scholar]
  44. Rao A, Craig AM. Activity regulates the synaptic localization of the NMDA receptor in hippocampal neurons. Neuron. 1997;19:801–812. doi: 10.1016/s0896-6273(00)80962-9. [DOI] [PubMed] [Google Scholar]
  45. Rao A, Kim E, Sheng M, Craig AM. Heterogeneity in the molecular composition of excitatory postsynaptic sites during development of hippocampal neurons in culture. J Neurosci. 1998;18:1217–1229. doi: 10.1523/JNEUROSCI.18-04-01217.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Rosenmund C, Feltz A, Westbrook GL. Synaptic NMDA receptor channels have a low open probability. J Neurosci. 1995;15:2788–2795. doi: 10.1523/JNEUROSCI.15-04-02788.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Sabatini BL, Maravall M, Svoboda K. Ca2+ signaling in dendritic spines. Curr Opin Neurobiol. 2001;11:349–356. doi: 10.1016/s0959-4388(00)00218-x. [DOI] [PubMed] [Google Scholar]
  48. Scherzer CR, Landwehrmeyer GB, Kerner JA, Counihan TJ, Kosinski CM, Standaert DG, et al. Expression of N-methyl-d-aspartate receptor subunit mRNAs in the human brain: hippocampus and cortex. J Comp Neurol. 1998;390:75–90. doi: 10.1002/(sici)1096-9861(19980105)390:1<75::aid-cne7>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  49. Shimizu E, Tang Y, Rampon I, Tsien JZ. NMDA receptor-dependent synaptic reinforcement as a crucial process for memory consolidation. Science. 2000;290:1170–1174. doi: 10.1126/science.290.5494.1170. [DOI] [PubMed] [Google Scholar]
  50. Sokolov MV, Rossokhin AV, Astrelin AV, Frey JU, Voronin LL. Quantal analysis suggests strong involvement of presynaptic mechanisms during the initial 3 h maintenance of long-term potentiation in rat hippocampal CA1 area in vitro. Brain Res. 2002;957:61–75. doi: 10.1016/s0006-8993(02)03600-4. [DOI] [PubMed] [Google Scholar]
  51. Sprengel R, Suchanek B, Amico C, Brusa R, Burnashev N, Rozov A, et al. Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo. Cell. 1998;92:279–289. doi: 10.1016/s0092-8674(00)80921-6. [DOI] [PubMed] [Google Scholar]
  52. Suzuki SS, Smith GK. Burst characteristics of hippocampal complex spike cells in the awake rat. Exp Neurol. 1985;89:90–95. doi: 10.1016/0014-4886(85)90267-5. [DOI] [PubMed] [Google Scholar]
  53. Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, et al. Genetic enhancement of learning and memory in mice. Nature. 1999;401:63–69. doi: 10.1038/43432. [DOI] [PubMed] [Google Scholar]
  54. Thompson CL, Drewery DL, Atkins HD, Stephenson FA, Chazot PL. Immunohistochemical localization of N-methyl-d-aspartate receptor subunits in the adult murine hippocampal formation: evidence for a unique role of the NR2D subunit. Brain Res Mol Brain Res. 2002;102:55–61. doi: 10.1016/s0169-328x(02)00183-3. [DOI] [PubMed] [Google Scholar]
  55. Tovar KR, Sprouffske K, Westbrook GL. Fast NMDA receptor-mediated synaptic currents in neurons from mice lacking the epsilon2 (NR2B) subunit. J Neurophysiol. 2000;83:616–620. doi: 10.1152/jn.2000.83.1.616. [DOI] [PubMed] [Google Scholar]
  56. Tovar KR, Westbrook GL. The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci. 1999;19:4180–4188. doi: 10.1523/JNEUROSCI.19-10-04180.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Tovar KR, Westbrook GL. Mobile NMDA receptors at hippocampal synapses. Neuron. 2002;34:255–264. doi: 10.1016/s0896-6273(02)00658-x. [DOI] [PubMed] [Google Scholar]
  58. Vicini S, Wang JF, Li JH, Zhu WJ, Wang YH, Luo JH, et al. Functional and pharmacological differences between recombinant N-methyl-d-aspartate receptors. J Neurophysiol. 1998;79:555–566. doi: 10.1152/jn.1998.79.2.555. [DOI] [PubMed] [Google Scholar]
  59. Williams K. Ifenprodil discriminates subtypes of the N-methyl-d-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors. Mol Pharmacol. 1993;44:851–859. [PubMed] [Google Scholar]
  60. Wittenberg GM, Tsien JZ. An emerging molecular and cellular framework for memory processing by the hippocampus. Trends Neurosci. 2002;25:501–505. doi: 10.1016/s0166-2236(02)02231-2. [DOI] [PubMed] [Google Scholar]
  61. Wyllie DJ, Behe P, Colquhoun D. Single-channel activations and concentration jumps: comparison of recombinant NR1a/NR2A and NR1a/NR2D NMDA receptors. J Physiol. 1998;510:1–18. doi: 10.1111/j.1469-7793.1998.001bz.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Yuste R, Tank DW. Dendritic integration in mammalian neurons, a century after Cajal. Neuron. 1996;16:701–716. doi: 10.1016/s0896-6273(00)80091-4. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Physiology are provided here courtesy of The Physiological Society

RESOURCES